Transgene Biotek Limited (TRANSGENE BIOTEK LTD.) aksje
TRABI.BO
StengtTRANSGENE BIOTEK LTD.
Market Cap
$234,129,296
Om Transgene Biotek Limited (TRANSGENE BIOTEK LTD.) aksje
Transgene Biotek Limited, a biotechnology company, provides research and development services for bulk drugs in India. It offers a portfolio of oncology drugs, oral drug delivery, and biogenerics. The company provides TrabiDHA for use in health food, baby food/formula, health supplement, and chicken and animal feed markets; Tacrolimus, a drug that suppresses the immune system and is used to prevent rejection of transplanted organs; and Orlistat (tetrahydrolipstatin), a lipase inhibitor that blocks about one-third of intestinal fat absorption. The company was incorporated in 1990 and is based in Sangareddy, India.
Selskapsinformasjon
502325 Sangareddy, India
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.